An industry leader in the emerging ketamine therapy space, Field Trip needed to carefully communicate a message of trust, hope, and scientific progress. After raising 120m in private equity they embarked on a thorough process of brand and product development where all touch points required a coherent message and ease of use in order to educate patients on the potential impact that this treatment can have in their lives. Patient data and ongoing field research was the primary avenue for validating the therapeutic methods through design, communication and brand strategy.